[2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate
C18H23F2NO3S — CID 11924257
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate
[2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate (PubChem CID 11924257) has the molecular formula C18H23F2NO3S and a molecular weight of 371.45 g/mol. Its IUPAC name is [2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate.
Molecular Properties
| Compound Name | [2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate |
|---|---|
| PubChem CID | 11924257 |
| Molecular Formula | C18H23F2NO3S |
| Molecular Weight | 371.45 g/mol |
| Exact Mass | 371.14 |
| IUPAC Name | [2-[[(1S,2R,3S)-2,3-dimethylcyclohexyl]amino]-2-oxoethyl] 2-(2,5-difluorophenyl)sulfanylacetate |
| SMILES | C[C@H]1[C@@H](NC(=O)COC(=O)CSc2cc(F)ccc2F)CCC[C@@H]1C |
| InChI | InChI=1S/C18H23F2NO3S/c1-11-4-3-5-15(12(11)2)21-17(22)9-24-18(23)10-25-16-8-13(19)6-7-14(16)20/h6-8,11-12,15H,3-5,9-10H2,1-2H3,(H,21,22)/t11-,12+,15-/m0/s1 |
| InChIKey | GEEQCQCCTINZFZ-ZOWXZIJZSA-N |
| XLogP | 3.54 |
| TPSA | 55.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 371.45 |
| LogP ≤ 5 | 3.54 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11924257 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.